HealthVerity and Claritas Rx partner to enhance real-world insights for life sciences 

HealthVerity and Claritas Rx have announced a collaboration to integrate real-world data (RWD) with specialty pharmacy insights, supporting commercial, real-world evidence (RWE), and health economics and outcomes research (HEOR) teams in developing a more complete understanding of patient access, adherence, and outcomes across the pharmaceutical lifecycle. 

The collaboration will combine HealthVerity’s extensive de-identified datasets with Claritas Rx’s specialty pharmacy, hub, and co-pay program data to create a unified, privacy-protected data offering for pharmaceutical manufacturers. By linking medical and pharmacy claims, electronic health records (EHRs), and laboratory data from HealthVerity with Claritas Rx’s specialty data, the partnership is designed to support a wide range of commercial and evidence-generation activities. 

The integrated resource aims to provide greater visibility into treatment access, speed-to-therapy, and adherence, supporting more informed decision-making across brand strategy, access planning, and evidence development. According to HealthVerity, this combined dataset will enable life sciences teams to better understand patient behavior and treatment dynamics. For commercial organizations, it can inform brand performance evaluation and targeting strategies, while for RWE and HEOR teams, it helps fill data gaps and enable longitudinal analyses from prescription to outcome.  

“Pharmaceutical companies are under increasing pressure to demonstrate access, effectiveness, and value with RWD,” said Andrew Goldberg, Chief Operating Officer and co-founder of HealthVerity. “This partnership gives our clients the depth and flexibility they need to do exactly that.”  

He added that by combining HealthVerity’s “Verified data ecosystem with specialty data expertise from Claritas Rx,” the collaboration will deliver “greater coverage, precision, and stability—key pillars for real-time decision-making.” 

Claritas Rx Chief Executive Officer Michael Fitzgibbons said the collaboration reflects a growing demand for more connected and actionable data.  

“We're thrilled to work with HealthVerity to meet the growing demand for integrated, actionable patient data,” he said. “Combining our specialty data insights with HealthVerity's scalable infrastructure gives commercial, RWE and HEOR teams a powerful 360-degree view into unique patient behavior and treatment dynamics.” 

The partnership will also allow pharmaceutical manufacturers using the Claritas Rx specialty aggregation platform to link their specialty pharmacy, hub, and co-pay data directly with HealthVerity’s research-grade RWD. This integration is expected to streamline access to insights for brand, commercial, RWE, and HEOR teams across the life sciences sector.